Term Name: EC 1.8.1.9 (thioredoxin reductase) inhibitor
Synonyms: EC 1.8.1.9 (thioredoxin reductase) inhibitors, EC 1.8.1.9 inhibitor, EC 1.8.1.9 inhibitors, NADP-thioredoxin reductase inhibitor, NADP-thioredoxin reductase inhibitors, NADPH-thioredoxin reductase inhibitor, NADPH-thioredoxin reductase inhibitors, NADPH2:oxidized thioredoxin oxidoreductase inhibitor, NADPH2:oxidized thioredoxin oxidoreductase inhibitors, thioredoxin reductase (EC 1.8.1.9) inhibitor, thioredoxin reductase (EC 1.8.1.9) inhibitors, thioredoxin reductase (NADPH) inhibitor, thioredoxin reductase (NADPH) inhibitors, thioredoxin reductase inhibitor, thioredoxin reductase inhibitors, thioredoxin-disulfide reductase inhibitor, thioredoxin-disulfide reductase inhibitors, thioredoxin:NADP+ oxidoreductase inhibitor, thioredoxin:NADP+ oxidoreductase inhibitors, TrxR inhibitor, TrxR inhibitors
Definition: An EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of thioredoxin reductase (EC 1.8.1.9).
Ontology: ChEBI [CHEBI:64670]  ( EBI )

Relationships
is a type of: EC 1.8.1.* (oxidoreductase acting on sulfur group of donors, NAD(+) or NADP(+) as acceptor) inhibitor
inverse has_role: auranofin curcumin manumycin A